These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10340555)

  • 81. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
    Pasanen T; Karppinen A; Alhonen L; Jänne J; Wahlfors J
    Int J Cancer; 2003 Apr; 104(3):380-8. PubMed ID: 12569563
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
    Wildner O; Morris JC
    J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
    Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
    [TBL] [Abstract][Full Text] [Related]  

  • 84. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Adenoviral-mediated suicide gene therapy for ovarian cancer.
    Alvarez RD; Gomez-Navarro J; Wang M; Barnes MN; Strong TV; Arani RB; Arafat W; Hughes JV; Siegal GP; Curiel DT
    Mol Ther; 2000 Nov; 2(5):524-30. PubMed ID: 11082326
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer.
    Freytag SO; Barton KN; Brown SL; Narra V; Zhang Y; Tyson D; Nall C; Lu M; Ajlouni M; Movsas B; Kim JH
    Mol Ther; 2007 Sep; 15(9):1600-6. PubMed ID: 17551507
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.
    Teh BS; Aguilar-Cordova E; Kernen K; Chou CC; Shalev M; Vlachaki MT; Miles B; Kadmon D; Mai WY; Caillouet J; Davis M; Ayala G; Wheeler T; Brady J; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Butler EB
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):605-13. PubMed ID: 11597799
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.
    Prados MD; McDermott M; Chang SM; Wilson CB; Fick J; Culver KW; Van Gilder J; Keles GE; Spence A; Berger M
    J Neurooncol; 2003 Dec; 65(3):269-78. PubMed ID: 14682377
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene.
    Shalev M; Miles BJ; Thompson TC; Ayala G; Butler EB; Aguilar-Cordova E; Kadmon D
    World J Urol; 2000 Apr; 18(2):125-9. PubMed ID: 10854147
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy.
    Kumon H; Ariyoshi Y; Sasaki K; Sadahira T; Araki M; Ebara S; Yanai H; Watanabe M; Nasu Y
    Cancer Gene Ther; 2016 Nov; 23(11):400-409. PubMed ID: 27767086
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter.
    Ahn M; Lee SJ; Li X; Jiménez JA; Zhang YP; Bae KH; Mohammadi Y; Kao C; Gardner TA
    Cancer Gene Ther; 2009 Jan; 16(1):73-82. PubMed ID: 18772902
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.
    Chiocca EA; Aguilar LK; Bell SD; Kaur B; Hardcastle J; Cavaliere R; McGregor J; Lo S; Ray-Chaudhuri A; Chakravarti A; Grecula J; Newton H; Harris KS; Grossman RG; Trask TW; Baskin DS; Monterroso C; Manzanera AG; Aguilar-Cordova E; New PZ
    J Clin Oncol; 2011 Sep; 29(27):3611-9. PubMed ID: 21844505
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer.
    Kwong YL; Chen SH; Kosai K; Finegold M; Woo SL
    Chest; 1997 Nov; 112(5):1332-7. PubMed ID: 9367477
    [TBL] [Abstract][Full Text] [Related]  

  • 95. In situ gene transfer and suicide gene therapy of gastric cancer induced by N-ethyl-N'-nitro-N-nitrosoguanidine in dogs.
    Matsukura N; Hoshino A; Igarashi T; Hasegawa H; Okino T; Onda M; Iijima O; Akiyama K; Goto T; Takubo K; Suzuki S; Shimada T
    Jpn J Cancer Res; 1999 Sep; 90(9):1039-49. PubMed ID: 10551335
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [The initial observation of adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system and photodynamic therapy for oral malignant tumor treatments].
    Chen S; Zhang Y; Fan Z; Li W; Guo Y; Wang X; Chen J; Li N
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Dec; 29(6):610-3, 617. PubMed ID: 22332573
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells.
    Suzuki S; Tadakuma T; Kunitomi M; Takayama E; Sato M; Asano T; Nakamura H; Hayakawa M
    Urol Int; 2001; 67(3):216-23. PubMed ID: 11598449
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome.
    Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD
    Brain Res; 1995 Sep; 691(1-2):76-82. PubMed ID: 8590067
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In situ gene therapy for prostate cancer.
    Satoh T; Irie A; Egawa S; Baba S
    Curr Gene Ther; 2005 Feb; 5(1):111-9. PubMed ID: 15638715
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Suicide gene therapy for chemically induced rat bladder tumor entailing instillation of adenoviral vectors.
    Akasaka S; Suzuki S; Shimizu H; Igarashi T; Akimoto M; Shimada T
    Jpn J Cancer Res; 2001 May; 92(5):568-75. PubMed ID: 11376567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.